Published in Chest on March 01, 1999
Pleurotomy with subxyphoid pleural drain affords similar effects to pleural integrity in pulmonary function after off-pump coronary artery bypass graft. J Cardiothorac Surg (2012) 0.86
Computed tomography evaluation of different chest tube sites for residual pleural volumes after coronary artery bypass surgery. Ann Saudi Med (2011) 0.82
Superior epigastric artery pseudoaneurysm--a rare complication of chest drain insertion in coronary artery bypass grafting. J Cardiothorac Surg (2007) 0.81
Pleural subxyphoid drain confers better pulmonary function and clinical outcomes in chronic obstructive pulmonary disease after off-pump coronary artery bypass grafting: a randomized controlled trial. Rev Bras Cir Cardiovasc (2015) 0.78
Subxiphoid versus intercostal chest tubes: comparison of postoperative pain and pulmonary morbidities after coronary artery bypass grafting. Tex Heart Inst J (2012) 0.77
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med (1991) 4.66
Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg (1996) 3.77
Intramural hemorrhage of the thoracic aorta. Diagnostic and therapeutic implications. Circulation (1995) 3.50
Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation (2000) 2.71
Attitude of patients toward transplantation of xenogeneic organs. Langenbecks Arch Surg (1999) 2.19
Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06
Coronary artery bypass grafting surgery without the routine application of blood products: Is it feasible? Eur J Cardiothorac Surg (2001) 2.02
Successful lung transplantation for posttraumatic adult respiratory distress syndrome after extracorporeal membrane oxygenation support. J Heart Lung Transplant (1992) 1.93
Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant (2010) 1.87
Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation (1991) 1.83
EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol (2009) 1.81
Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation (1987) 1.81
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart (2003) 1.76
Different approaches for minimally invasive closure of atrial septal defects. Ann Thorac Surg (1999) 1.75
Myocardial calcification after orthotopic heart transplantation. J Heart Transplant (1988) 1.53
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology (2000) 1.50
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49
Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J Thorac Cardiovasc Surg (2006) 1.48
Bronchial circulation after experimental lung transplantation. The effect of long-term administration of prednisolone. J Thorac Cardiovasc Surg (1993) 1.47
Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant (2001) 1.47
A new minimally invasive approach to the subclavian artery. Ann Thorac Surg (1998) 1.46
Clinical evaluation of transtracheal Doppler for continuous cardiac output estimation. Anesth Analg (1992) 1.45
Therapy for lung failure using nitric oxide inhalation and surfactant replacement. Ann Thorac Surg (1996) 1.45
Cardiac surgery in Germany during 2008. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2009) 1.45
Ten year survival after heart transplantation: palliative procedure or successful long term treatment? Heart (1999) 1.43
Matched-pair analysis of conventional versus endoluminal AAA treatment outcomes during the initial phase of an aortic endografting program. J Endovasc Ther (2000) 1.40
Aortic valve replacement with the pulmonary autograft--experience of 23 cases. Thorac Cardiovasc Surg (1992) 1.39
Hyperacute rejection in heart allografts. Case studies. Pathol Res Pract (1991) 1.39
Explantation of the heart for resection of primary cardiac tumors can be avoided by partial ex situ heart surgery. Thorac Cardiovasc Surg (2003) 1.39
Retrograde versus antegrade crystalloid cardioplegia in coronary surgery: value of troponin-I measurement. Ann Thorac Surg (2001) 1.39
Preoperative corticosteroids. A contraindication to lung transplantation? Chest (1992) 1.39
Coarctation of the aorta in complex congenital heart disease: simultaneous repair via sternotomy. Eur J Cardiothorac Surg (1990) 1.39
Rapid identification of viral infections in liver, heart, and kidney allograft biopsies by in situ hybridization. Am J Surg Pathol (1989) 1.38
Aortic valve replacement: is the stentless xenograft an alternative to the homograft? Midterm results. Ann Thorac Surg (1999) 1.38
Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg (1998) 1.36
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation (2000) 1.35
Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation (2000) 1.25
Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth (2009) 1.24
Chronic hepatitis e in heart transplant recipients. Am J Transplant (2012) 1.18
Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant (2009) 1.15
Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis (2010) 1.13
Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res (2002) 1.12
Transposition of the greater omentum for management of mediastinal infection following orthotopic heart transplantation: a case report. J Heart Transplant (1987) 1.11
Fibrin adhesive: an important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg (1982) 1.09
Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant (1999) 1.08
Impact of preoperative aortic root diameter on long-term aortic valve function after valve sparing aortic root reimplantation. Circulation (2003) 1.06
Acute and chronic aortic dissections--determinants of long-term outcome for operative survivors. Circulation (1985) 1.04
Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant (2011) 1.04
A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog (2000) 1.02
Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther (2005) 1.02
Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res (1992) 1.01
Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg (1996) 1.00
Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg (2001) 0.97
Effects of minimal invasive coronary artery bypass on pulmonary function and postoperative pain. Ann Thorac Surg (2000) 0.97
Laser printing of cells into 3D scaffolds. Biofabrication (2010) 0.97
Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int (1998) 0.97
Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg (1994) 0.97
Tissue engineering of vascular grafts: human cell seeding of decellularised porcine matrix. Eur J Vasc Endovasc Surg (2000) 0.96
Proximal aortic dissection late after aortic valve surgery: 119 cases of a distinct clinical entity. Thorac Cardiovasc Surg (2000) 0.96
Predictors of proximal aortic dissection at the time of aortic valve replacement. Circulation (1999) 0.96
Immunosuppressive therapy after human lung transplantation. Eur Respir J (2004) 0.96
Microcirculation of the sternum following harvesting of the left internal mammary artery. Thorac Cardiovasc Surg (2003) 0.95
Video-assisted minimally invasive approach in clinical bilateral lung transplantation. J Thorac Cardiovasc Surg (2001) 0.95
Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials (2003) 0.95
In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg (2002) 0.94
Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation (2000) 0.93
Single-channel properties of L-type calcium channels from failing human ventricle. Cardiovasc Res (1998) 0.93
Status of patients presently living 9 to 13 years after orthotopic heart transplantation. Ann Thorac Surg (1997) 0.93
Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension. Eur J Cardiothorac Surg (1998) 0.92
Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons. Transplant Proc (1999) 0.92
[Rabies transmission through organ transplantation]. Pathologe (2011) 0.92
Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg (1999) 0.92
Management of mycotic rupture of the ascending aorta after heart-lung transplantation. Ann Thorac Surg (1990) 0.91
Valve sparing aortic root reconstruction versus composite replacement -- perioperative course and early complications. Eur J Cardiothorac Surg (2001) 0.90
Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant (1999) 0.90
Ascending aortic replacement with aortic valve reimplantation. Circulation (1999) 0.90
Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med (1998) 0.90
Cytoimmunologic monitoring in early and late acute cardiac rejection. J Heart Transplant (1988) 0.90
Cardiac surgery in Germany during 2007: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg (2008) 0.90
The role of cerebrospinal fluid S100 and lactate to predict clinically evident spinal cord ischaemia in thoraco-abdominal aortic surgery. Eur J Vasc Endovasc Surg (2008) 0.89
[Orthotopic heart transplantation in childhood and adolescence]. Monatsschr Kinderheilkd (1988) 0.89
Predictors of lung transplant survival in eurotransplant. Am J Transplant (2003) 0.89
Surgical alternatives in the treatment of life-threatening ventricular arrhythmias. Eur J Cardiothorac Surg (1988) 0.89
The use of gelatin-resorcin-formalin glue in acute aortic dissection type A. Eur J Cardiothorac Surg (1999) 0.89
Acute dissection of the ascending aorta: first results of emergency valve sparing aortic root reconstruction. Eur J Cardiothorac Surg (2002) 0.88